In severe human p-thalassemia, the pathophysiology relates t o accumulation of excess arglobin chains at the membrane. One hypothesis is that membrane-associated a-globin by virtue of it's iron or hemichromes produces oxidation of adjacent membrane proteins. The availability of a mouse model of severe @thalassemia, as well as a transgenic (thalassemic-sickle) mouse that expresses 12% of human p'-chain, has allowed us t o study the effect of graded accumulation of archains at the red blood cell (RBC) membrane on the clinical status of the animal and on the material properties of its RBCs. Proteins from control, p-thalassemic, and transgenic mouse RBC membranes were analyzed for evidence of oxidation, as measured by thiol-disulfide exchange chromatography, which detects intramolecular sulfhydryl oxidation. Ratios of oxidized globin t o protein 7 were calculated and increased amounts were seen in thalassemic HE HALLMARK of the thalassemias is an imbalance T in globin chain synthesis. In human P-thalassemia, a very heterogenous group of disorders, there is defective P-globin synthesis, which leads to deficiency of hemoglobin per red blood cell (RBC) and to an excess of a-globin chains.' These chains accumulate in a manner that probably causes a premature destruction of RBCs and their precursors in the bone marrow and peripheral blood.
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When the material properties of RBCs from patients with severe P-thalassemia are analyzed, the RBC membrane is seen to be both rigid and unstable.' The instability is manifested by premature fragmentation of ghosts when subjected to fluid shear stresses. The excess a-globin chains accumulate at the membrane and more particularly at its skeleton.' We propose that oxidation of adjacent membrane proteins occurs, perhaps mediated by the associated iron or hemichromes, thereby accounting for the markedly abnormal material properties. The heterogeneity of human P-thalassemia makes it difficult to relate the amount and sort of oxidized membrane protein to abnormal membrane material properties.
The mouse models of P-thalassemia' offer the advantage mice as compared with control mice and transgenic mice. Furthermore, there were increased amounts of thiol-free protein 4.1 in the thalassemic mice, compared with very small amounts in the control mice and intermediate amounts in the transgenic mice. Membrane mechanical stability as assessed by ektacytometry showed that the thalassemic mouse RBCs were markedly unstable. Transgenic mouse RBCs showed intermediate levels of membrane instability compared with the controls. We propose that this oxidized globin, in conjunction with oxidized protein 4.1, accounts (at least in part) for membrane instability. A 12% increase in p'-globin chain synthesis (by decreasing excess globin available) confers considerable protection against both oxidative damage and the consequent membrane instability. o 1992 by The American Society of Hematology.
of lack of the heterogeneity seen in the human disorder. Furthermore, a transgenic (thalassemic-sickle hemoglobin) mouse' is available that expresses approximately 12% of human v-chains and thereby reduces the amount of excess a-globin chains: The availability of thalassemic and transgenic mice allowed us to study the effect of graded accumulation of a-globin chains at the RBC membrane on the clinical status of the animal and on the material properties of the RBC and to correlate these changes with observations on the extent of membrane protein oxidation.
MATERIALS AND METHODS

Materials.
Sodium dodecyl sulfate (SDS) was obtained from BHD Chemicals (Poole, UK). Diisopropylfluorophosphate (DFP), leupeptin, pepstatin, phenyl-methyl-sulfonyl-fluoride (PMSF), and deferoxamine were obtained from Sigma Chemical (St Louis MO). Beta-mercaptoethanol (BME) and urea were purchased from BioRad Laboratories (Richmond, CA). Thiol-activated Sepharose 4B was obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). Anti-4.1 was obtained from Dr Joel Chasis and was an affinity-purified monospecific polyclonal rabbit antibody against purified human RBC protein 4.1. Protein 4.1 is highly conserved and the antibody cross-reacts with mouse RBC membrane protein 4.1.
Normal mice (C57BL/6 strain), thalassemic mice, and transgenic (thalassemic-sickle) mice were bred at the Lawrence Berkeley Laboratory, (Berkeley, CA). Blood was drawn from these mice by retro-orbital venipuncture. The RBCs were washed in saline and hematocrit adjusted to 50% with isotonic saline. Based on our experience with the human thalassemics, control, thalassemic, and transgenic mice RBC were treated with proteolysis inhibitors (final concentration, 2 mmol/L DFP, and 10 pg/mL of leupeptin and pep~tatin)~ before membranes were prepared' by hypotonic lyses with five washes in 20 vol of degassed, cold, 5 mmol/L sodium phosphate buffer at pH 8.0 containing 100 mg/L PMSF and 0.1 mmol/L EDTA. Aliquots of these membranes were solubilized in 1/9th the volume of 20% SDS, followed by boiling for 5 minutes and analysis by thiol-disulfide exchange chromatography? This method is based on the principle that proteins, which contain reduced thiols, bind to the thiol-activated agarose gel.
Methods.
Those proteins appearing in the unbound fraction either have no free thiols or their thiols have been blocked or converted into disulfides. Proteins with free thiols were bound to the thiol-MEMBRANE OXIDATION IN B-THALASSEMIA 1065 activated sepharose and subsequently were eluted by the addition of PME as described.'
PMSF ( I 0 0 mg/L) and EDTA (0.1 mmol/L) were added to inhibit proteases during the subsequent steps where samples were eluted: dialyzed' (exclusion limit, 1,OOO d), concentrated with Minicons B15 (Amicon, Beverly, MA), and analyzed by 6% to 18% polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie blue as previously descn'bed." Gels were analyzed by laser densitometry using an LKB Ultroscan XL (2222-020; Bromma, Sweden). Western blots were performed as described' on the unbound fractions obtained from the thiol columns, using a monospecific polyclonal rabbit antibody raised against purified human protein 4.1 (see Materials).
For comparison, it is known that in normal human RBC membranes only two proteins-glycophorin A and band 7-appear in the unbound fraction, because these proteins natively have no free thiols. Because it is not always possible to process identical numbers of RBC? from each of the mice, the amount of each type of protein appearing in the unbound fraction is normalized to the protein 7 content as measured by laser densitometry of the Coomassie blue-stained gels.
To rule out the possibility that the murine thalassemic RBC might contain more heme-linked iron, which in tum could cause iron-mediated oxidation during either preparation of ghosts or during subsequent thiol-disulfide exchange chromatography, we performed the following experiments. One freshly drawn murine p-thalassemic sample was split into two aliquots. One aliquot was thioldisulfide exchange chromatography. The unbound fractions were concentrated and then the ghosts and these fractions were analyzed by SDS-PAGE (Fig 1) . Proteins with the electrophoretic mobility of globin appeared in increased amounts in the unbound fraction (no free thiols) of both thalassemic and transgenic mice (Fig 1) . The globin to protein 7 ratios are shown in Table 1 . Increased amounts of globin are seen in the thalassemic mice (mean ratio, 18.5) as compared with control mice (mean ratio, 3.5) and transgcnic mice (mean ratio, 10.5).
A protein with the electrophoretic mobility of protein 4.1 also appears in the unbound fraction of thalassemic mice, but not in the fraction from RBCs of control mice. Only faint traces of protein 4.1 appear in the unbound fraction of transgenic mice (Fig 1) . Because abnormality of the function of protein 4.1 has been described in severe human f3-thalassemia," it was important to be sure that protein 4.1 in thalassemic mice had indeed lost its free thiols. Theretreated as dem'bed above,-while the other-aliquot was lykd and analyzed with 0.5 mmollL deferoxamine added to all solutions to chelate any iron present.' Ektacytometric analysis of RBC membrane mechanical stability was performed as previously descriid? fore, Wcstem blotting was prformed using a monospecific polyclonal rabbit a n t i m y raised against purified human RBC protein 4.1 to confirm the identity of the oxidized protein in the unbound fraction. A.
in ~i~ 2, oxidized protein 4.1 is indeed a component of the unbound fraction.
RESULTS
Ghosts from control, thalassemic, and transgenic mice were prepared and solubilized in SDS and then subjected to Identical findings on globin and protein 4.1 oxidation were obtained when deferoxamine was included in all the buffers used during preparation and subsequent analysis of the membranes. This observation suggests that the membrane oxidative changes noted in thalassemic RBCs have occured in situ and not during the experimental manipulations.
The relationship of a critical membrane material property, ie, membrane instability to the observed changes in membrane protein oxidation, is shown in Fig 3. When compared with normal mouse membranes, P-thalassemic membranes are markedly more mechanically unstable, as evidenced by a faster rate of decline of deformability index with time. In contrast, membranes from transgenic mice exhibited mechanical stability values intermediate between those of P-thalassemic and normal RBC membranes.
DISCUSSION
The homozygous mouse phenotype appears to be an excellent model for human P-thalassemia intermedia with similar degrees of anemia and clinical incapacity. The RBC membranes of thalassemic mice contain increased amounts of globin, some of which is devoid of free thiols. The absence of free thiols most probably indicates that the globin has been oxidized. The RBC membranes of transgenic mice also contain increased amounts of thiol-free globin, but the values are intermediate between those of control and thalassemic mice. In a prior study: we showed that most of this membrane-associated globin is made up of a-chains.
Interestingly, in addition to oxidized a-globin, we also find an increase in thiol-free protein 4.1 in the membranes of thalassemic RBCs. In contrast, no thiol-free protein 4.1 is found in normal RBC membranes, while only small amounts of thiol-free protein 4.1 are noted in the RBC membranes of the transgenic mouse.
In interpreting these data, it is important to remember that only proteins completely devoid of free sulfhydryls appear in the unbound fraction of the thiol-disulfide column. Thus, if six of the seven thiols of a protein 4.1 molecule9 are oxidized, it still has the capacity to bind to the thiol-activated sepharose and not appear in the unbound fraction. The same is true for the two thiols of a-globin. Furthermore, oxidation of tyrosines, methionine, and histidine is not detected at all by this method, although they are also prone to oxidant stress." Therefore, thiol-disulfide chromatography underestimates oxidative attack. The RBC membranes of thalassemic mice are unstable and fragment more readily than membranes of control mice. The RBC membranes of transgenic mice are also unstable, but the degree of instability is intermediate, between that of thalassemic and control mouse membranes. In the two types of thalassemic mice studied, there is a relationship between disease severity and the amount of thiol-free globin bound to the membrane, the amount of thiol-free protein 4.1 in the membrane, and the membrane mechanical stability. The observation of oxidation of some protein 4.1 in p-thalassemic mice supports a prior observation in humans, showing that purified protein 4.1 from such patients is functionally abnormal, binds poorly to spectrin, and participates suboptionally in mediating the formation of the spectrinactin-protein 4.1 tertiary complex.8 RBC membranes deficient in protein 4.1 are mechanically unstable and the membrane stability can be restored toward normal by resealing normal protein 4.1 within such protein 4.1deficient ghosts." Therefore, it is possible that oxidation of protein 4.1 contributes to the observed instability of thalassemic RBC membranes, although the amount of oxidized protein 4.1 detected is far below the amount reported to be deficient in patients with severe protein 4.1 deficiency."
The results with the transgenic mouse show that even a very modest increase in P-chain synthesis in the order of 12% produces striking clinical benefit, paralleled by a reduction in thiol-depleted globin and thiol-depleted protein 4.1 at the RBC membrane. These results, showing a correlation between thiol-free globin content and abnormal material properties, support the hypothesis that the excess a-globin chains in severe P-thalassemia produce their pathophysiologic effects (at least in part) by their susceptibility to oxidation and by somehow transmitting this oxidative insult to specific proteins in the RBC membrane.
These studies on mouse thalassemia and a transgenic thalassemic variant allowed us to make quantitative analysis on a single thalassemic strain with graded disease severity. The gradation is reflected in the amount of oxidized globin bound to the membrane and its skeleton and in the amount of protein 4.1 oxidized. These results support and confirm the results seen in severe human P-thalassemia.
